Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023

血液分析装置・試薬の世界市場予測(~2023年)

◆タイトル:Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023
◆商品コード:MD-2479
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年6月12日
◆ページ数:170
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、血液分析装置・試薬の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品・サービス別分析、価格別分析、需要先別分析、地域別分析、血液分析装置・試薬の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The hematology products market projected to grow at a CAGR of 8.5%.”The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. Technological advancements in hematology analyzers and reagents, integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent.

“High-end hematology analyzers segment is expected to be the fastest-growing segment during the forecast period.”
By price range, the hematology instruments market is segmented into high-end, mid-range, and low-end hematology analyzers. The high-end hematology analyzers segment is expected to register the highest growth during the forecast period. The high growth of this segment is attributed to the reliability, high accuracy, flexibility, ease of use, and multi-parameter testing capabilities of high-end hematology analyzers.

“Asia Pacific is expected to grow at the highest CAGR during the forecast period.”
Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing geriatric population coupled with the growing incidence of thalassemia, sickle cell anemia, and leukemia. Moreover, improved healthcare infrastructure in countries like Japan, China, and Australia; rising number of general surgeries and organ transplantations; and the growing number of ongoing research activities are other factors also contributing to the high growth of this segment.

Breakdown of supply-side primary interviews:
• By Company Type – Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%

The major players of the hematology analyzers and reagents market are Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland) among others.

Research Coverage

This report studies the hematology analyzers and reagents market based on products and services; the hematology products & services market is further categorized on the basis of price range, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report focuses on various levels of analysis— market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the hematology analyzers and reagents market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKETS COVERED 15
1.3.1 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY USED 16
1.5 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH METHODOLOGY STEPS 17
2.2 SECONDARY RESEARCH 19
2.3 PRIMARY RESEARCH 21
2.4 MARKET SIZE ESTIMATION METHODOLOGY 22
2.4.1 BOTTOM-UP APPROACH 23
2.4.2 TOP-DOWN APPROACH 24
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.6 RESEARCH ASSUMPTIONS 26
2.7 RESEARCH LIMITATIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW 31
4.2 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT AND SERVICE,
2018 VS. 2023 (USD MILLION) 32
4.3 HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2018 VS. 2023 (USD MILLION) 33
4.4 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY END USER,
2018 VS. 2023 (USD MILLION) 34
4.5 HEMATOLOGY INSTRUMENTS MARKET, BY COUNTRY (2018–2023) 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Rise in blood donation 37
5.2.1.2 Increasing incidence of blood disorders 37
5.2.1.3 Technological advancements 38
5.2.1.4 Integration of hematology analyzers with flow cytometry 39
5.2.2 RESTRAINTS 39
5.2.2.1 Product recalls and safety alerts 39
5.2.2.2 Slow adoption of advanced hematology instruments in emerging countries 40
5.2.3 OPPORTUNITIES 40
5.2.3.1 Growing use of automated hematology analyzers 40
5.2.3.2 Market penetration opportunities in emerging countries 41
5.2.3.3 Rising awareness among end users about advanced hematology analyzers 42
5.2.3.4 Emergence of microfluidics technology 42
5.2.4 CHALLENGES 43
5.2.4.1 High cost of advanced hematology analyzers 43
5.2.4.2 Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches 43
5.2.5 INDUSTRY TREND 44
5.2.5.1 Growing reagent rental business 44
6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE 45
6.1 INTRODUCTION 46
6.2 HEMATOLOGY PRODUCTS & SERVICES 47
6.2.1 INSTRUMENTS 49
6.2.1.1 5-part and 6-part fully automated hematology analyzers 51
6.2.1.2 3-part fully automated hematology analyzers 52
6.2.1.3 Semi-automated hematology analyzers 53
6.2.1.4 Point-of-care testing hematology analyzers 54
6.2.2 REAGENTS & CONSUMABLES 55
6.2.2.1 Hematology reagents 56
6.2.2.2 Slide stainers/makers 57
6.2.2.3 Controls and calibrators 58
6.2.2.4 Consumables 59
6.2.3 SERVICES 60
6.3 HEMOSTASIS PRODUCTS & SERVICES 61
6.3.1 INSTRUMENTS 63
6.3.2 REAGENTS & CONSUMABLES 63
6.3.3 SERVICES 64
6.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES 65
6.4.1 INSTRUMENTS 67
6.4.2 REAGENTS & CONSUMABLES 68
6.4.3 SERVICES 69

7 HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE 70
7.1 INTRODUCTION 71
7.2 HIGH-END HEMATOLOGY ANALYZERS 72
7.3 MID-RANGE HEMATOLOGY ANALYZERS 73
7.4 LOW-END HEMATOLOGY ANALYZERS 74
8 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY END USER 75
8.1 INTRODUCTION 76
8.2 HOSPITAL LABORATORIES 77
8.3 COMMERCIAL SERVICE PROVIDERS 78
8.4 GOVERNMENT REFERENCE LABORATORIES 80
8.5 RESEARCH AND ACADEMIC INSTITUTES 81
9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION 83
9.1 INTRODUCTION 84
9.2 NORTH AMERICA 86
9.2.1 US 90
9.2.2 CANADA 91
9.3 EUROPE 92
9.3.1 GERMANY 97
9.3.2 FRANCE 97
9.3.3 UK 98
9.3.4 REST OF EUROPE 99
9.4 ASIA PACIFIC 100
9.4.1 JAPAN 104
9.4.2 CHINA 106
9.4.3 INDIA 107
9.4.4 REST OF ASIA PACIFIC 108
9.5 REST OF THE WORLD 109
10 COMPETITIVE LANDSCAPE 114
10.1 INTRODUCTION 114
10.2 GLOBAL MARKET SHARE ANALYSIS 115
10.3 COMPETITIVE SCENARIO 116
10.3.1 MAJOR PRODUCT LAUNCHES AND ENHANCEMENTS (2015–2018) 116
10.3.2 MAJOR AGREEMENTS (2015–2018) 117
10.3.3 MAJOR GEOGRAPHIC EXPANSIONS (2015–2018) 117
10.3.4 MAJOR STRATEGIC ACQUISITIONS AND MERGERS (2015–2018) 118

11 COMPANY PROFILES 119
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 ABBOTT 119
11.2 BIO-RAD LABORATORIES 122
11.3 BIOSYSTEMS (A PART OF GINPER GROUP) 125
11.4 BOULE 127
11.5 DANAHER 131
11.6 DIATRON 134
11.7 DREW SCIENTIFIC 136
11.8 EKF DIAGNOSTICS 137
11.9 HORIBA 139
11.10 MINDRAY 143
11.11 NIHON KOHDEN 146
11.12 ORTHO CLINICAL DIAGNOSTICS 148
11.13 ROCHE 150
11.14 SIEMENS 152
11.15 SYSMEX 155
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 160
12.1 DISCUSSION GUIDE 160
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 165
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 167
12.4 AVAILABLE CUSTOMIZATIONS 167
12.5 RELATED REPORTS 168
12.6 AUTHOR DETAILS 169

LIST OF TABLES

TABLE 1 NUMBER OF BLOOD DONATIONS, BY COUNTRY (2015) 37
TABLE 2 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 46
TABLE 3 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 48
TABLE 4 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 48
TABLE 5 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 50
TABLE 6 HEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 50
TABLE 7 5-PART AND 6-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET,
BY REGION, 2016–2023 (USD MILLION) 52
TABLE 8 3-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2016–2023 (USD MILLION) 53
TABLE 9 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION,
2016–2023 (USD MILLION) 54
TABLE 10 POINT-OF-CARE TESTING HEMATOLOGY ANALYZERS MARKET, BY REGION,
2016–2023 (USD MILLION) 55
TABLE 11 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 55
TABLE 12 HEMATOLOGY REAGENTS AND CONSUMABLES MARKET, BY REGION,
2016–2023 (USD MILLION) 56
TABLE 13 HEMATOLOGY REAGENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 14 HEMATOLOGY SLIDE STAINERS/MAKERS MARKET, BY REGION,
2016–2023 (USD MILLION) 58
TABLE 15 HEMATOLOGY CONTROLS AND CALIBRATORS MARKET, BY REGION,
2016–2023 (USD MILLION) 59
TABLE 16 HEMATOLOGY CONSUMABLES MARKET, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 17 HEMATOLOGY SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 18 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 62
TABLE 19 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 62
TABLE 20 HEMOSTASIS INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 21 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY REGION,
2016–2023 (USD MILLION) 64
TABLE 22 HEMOSTASIS SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 23 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 66
TABLE 24 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 66
TABLE 25 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 67
TABLE 26 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION,
2016–2023 (USD MILLION) 68
TABLE 27 IMMUNOHEMATOLOGY SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 69
TABLE 28 HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 71
TABLE 29 HIGH-END HEMATOLOGY INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 72
TABLE 30 MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2016–2023 (USD MILLION) 73
TABLE 31 LOW-END HEMATOLOGY INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 74
TABLE 32 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 77
TABLE 33 HEMATOLOGY PRODUCTS & SERVICES MARKET FOR HOSPITAL LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 78
TABLE 34 HEMATOLOGY PRODUCTS & SERVICES MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2016–2023 (USD MILLION) 79
TABLE 35 HEMATOLOGY PRODUCTS & SERVICES MARKET FOR GOVERNMENT REFERENCE LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 81
TABLE 36 HEMATOLOGY PRODUCTS & SERVICES MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2016–2023 (USD MILLION) 82
TABLE 37 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 84
TABLE 38 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 84
TABLE 39 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 85
TABLE 40 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 87
TABLE 41 NORTH AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 87
TABLE 42 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 88
TABLE 43 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 88
TABLE 44 NORTH AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 89
TABLE 45 NORTH AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 89
TABLE 46 NORTH AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 47 US: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 91
TABLE 48 CANADA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 91
TABLE 49 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 94
TABLE 50 EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 94
TABLE 51 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 95
TABLE 52 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 95
TABLE 53 EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 96
TABLE 54 EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 96
TABLE 55 EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 96
TABLE 56 GERMANY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 97
TABLE 57 FRANCE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 98
TABLE 58 UK: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 99
TABLE 59 ROE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 100
TABLE 60 APAC: HEMATOLOGY INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 102
TABLE 61 APAC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 102
TABLE 62 APAC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 102
TABLE 63 APAC: HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 103
TABLE 64 APAC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 103
TABLE 65 APAC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 104
TABLE 66 APAC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 104
TABLE 67 JAPAN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 105
TABLE 68 CHINA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 106
TABLE 69 INDIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 107
TABLE 70 ROAPAC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 108
TABLE 71 ROW: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 111
TABLE 72 ROW: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 111
TABLE 73 ROW: HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2016–2023 (USD MILLION) 111
TABLE 74 ROW: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 112
TABLE 75 ROW: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 112
TABLE 76 ROW: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 113


LIST OF FIGURES

FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 KEY DATA FROM SECONDARY SOURCES 19
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 21
FIGURE 5 BREAKDOWN OF PRIMARIES 22
FIGURE 6 BOTTOM-UP APPROACH 23
FIGURE 7 TOP-DOWN APPROACH 24
FIGURE 8 DATA TRIANGULATION 25
FIGURE 9 ASSUMPTIONS OF THE RESEARCH STUDY 26
FIGURE 10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD MILLION) 27
FIGURE 11 HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE,
2018 VS. 2023 (USD MILLION) 28
FIGURE 12 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY END USER (2018) 29
FIGURE 13 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY REGION (2017) 30
FIGURE 14 INCREASING INCIDENCE OF BLOOD DISORDERS TO DRIVE THE HEMATOLOGY ANALYZERS & REAGENTS MARKET DURING 2018–2023 31
FIGURE 15 HEMATOLOGY PRODUCTS AND SERVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2023 32
FIGURE 16 LOW-END HEMATOLOGY ANALYZERS TO DOMINATE THE HEMATOLOGY INSTRUMENTS MARKET IN 2018 VS 2023 33
FIGURE 17 COMMERCIAL SERVICE PROVIDERS TO DOMINATE THE HEMATOLOGY PRODUCTS AND SERVICES MARKET IN 2018 34
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR IN THE HEMATOLOGY INSTRUMENTS MARKET DURING THE FORECAST PERIOD 35
FIGURE 19 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 20 ANNUAL HEALTHCARE EXPENDITURE (% OF GDP): DEVELOPED VS. DEVELOPING COUNTRIES (2010 VS. 2014) 41
FIGURE 21 HEMATOLOGY PRODUCTS AND SERVICES MARKET TO GARNER HIGHER REVENUE COMPARED TO HEMOSTASIS AND IMMUNOHEMATOLOGY SEGMENTS TILL 2023 46
FIGURE 22 REAGENTS & CONSUMABLES SEGMENT TO DOMINATE THE HEMATOLOGY PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD 47
FIGURE 23 5 & 6-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS SEGMENT TO DOMINATE THE HEMATOLOGY INSTRUMENTS MARKET DURING
THE FORECAST PERIOD 49
FIGURE 24 REAGENTS AND CONSUMABLES SEGMENT TO DOMINATE THE HEMOSTASIS PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD 61
FIGURE 25 REAGENTS & CONSUMABLES TO DOMINATE THE IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD 65
FIGURE 26 LOW-END HEMATOLOGY ANALYZERS SEGMENT TO DOMINATE THE HEMATOLOGY INSTRUMENTS MARKET, BY PRICE RANGE, DURING THE FORECAST PERIOD 71
FIGURE 27 COMMERCIAL SERVICE PROVIDERS TO DOMINATE THE HEMATOLOGY PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD 76
FIGURE 28 NORTH AMERICA: HEMATOLOGY PRODUCTS AND SERVICES MARKET SNAPSHOT 86
FIGURE 29 EUROPE: HEMATOLOGY PRODUCTS AND SERVICES MARKET SNAPSHOT 93
FIGURE 30 APAC: HEMATOLOGY PRODUCTS AND SERVICES MARKET SNAPSHOT 101
FIGURE 31 ROW: HEMATOLOGY PRODUCTS AND SERVICES MARKET SNAPSHOT 110
FIGURE 32 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE MARKET,
2015–2018 114
FIGURE 33 GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET SHARE,
KEY PLAYER (2017) 115
FIGURE 34 ABBOTT: COMPANY SNAPSHOT 119
FIGURE 35 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 122
FIGURE 36 BOULE DIAGNOSTICS: COMPANY SNAPSHOT 127
FIGURE 37 DANAHER: COMPANY SNAPSHOT 131
FIGURE 38 EKF DIAGNOSTICS: COMPANY SNAPSHOT 137
FIGURE 39 HORIBA: COMPANY SNAPSHOT 139
FIGURE 40 NIHON KOHDEN: COMPANY SNAPSHOT 146
FIGURE 41 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 150
FIGURE 42 SIEMENS: COMPANY SNAPSHOT 152
FIGURE 43 SYSMEX: COMPANY SNAPSHOT 155


【レポートのキーワード】

血液分析装置、血液分析試薬

★調査レポート[血液分析装置・試薬の世界市場予測(~2023年)] ( Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023 / MD-2479) 販売に関する免責事項
[血液分析装置・試薬の世界市場予測(~2023年)] ( Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023 / MD-2479) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆